Symbols / EMBC Stock $3.41 +2.71% Embecta Corp.
EMBC (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteEmbecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-05-18 | main | B of A Securities | Underperform → Underperform | $3 |
| 2026-05-06 | main | Mizuho | Neutral → Neutral | $5 |
| 2026-05-06 | down | BTIG | Buy → Neutral | — |
| 2026-04-13 | main | Mizuho | Neutral → Neutral | $12 |
| 2026-02-06 | reit | BTIG | Buy → Buy | $25 |
| 2025-09-05 | reit | BTIG | Buy → Buy | $25 |
| 2025-07-16 | main | Mizuho | Neutral → Neutral | $12 |
| 2025-05-23 | main | Mizuho | Neutral → Neutral | $13 |
| 2025-04-10 | init | Mizuho | — → Neutral | $15 |
| 2024-11-27 | up | BTIG | Neutral → Buy | $26 |
| 2024-07-15 | main | Morgan Stanley | Underweight → Underweight | $12 |
| 2024-05-10 | main | Morgan Stanley | Underweight → Underweight | $13 |
| 2023-11-22 | main | Morgan Stanley | Underweight → Underweight | $16 |
| 2023-10-18 | main | Morgan Stanley | Underweight → Underweight | $15 |
| 2023-08-24 | main | Morgan Stanley | Underweight → Underweight | $16 |
| 2023-07-18 | main | Morgan Stanley | Underweight → Underweight | $19 |
| 2023-05-15 | main | Morgan Stanley | Underweight → Underweight | $29 |
| 2023-01-06 | down | Morgan Stanley | Equal-Weight → Underweight | $28 |
| 2022-12-21 | main | Morgan Stanley | — → Equal-Weight | $31 |
| 2022-10-11 | main | Morgan Stanley | — → Equal-Weight | $33 |
- Deeply Undervalued Global Medical Device Company – Embecta Corp. (EMBC) - The Acquirer's Multiple hu, 07 May 2026 07
- Embecta Corp. (EMBC) grants 30,000 shares to VP, Chief Accounting Officer - Stock Titan ue, 02 Jun 2026 21
- Embecta (EMBC): Do Buybacks Amid Losses Reveal Capital Discipline or Strategic Uncertainty? - Yahoo Finance Wed, 06 May 2026 07
- EMBC Investor Alert: Levi & Korsinsky Investigates Embecta Corp. (EMBC) for Potential Securities Fraud - Morningstar Wed, 13 May 2026 07
- EMBC Technical Analysis & Stock Price Forecast - Intellectia AI Sun, 31 May 2026 21
- Embecta ‘disappointed’ with Q2 results that fell below expectations, cuts 2026 guidance - Drug Delivery Business ue, 05 May 2026 07
- Four U.S. cities in June as embecta meets healthcare investors - Stock Titan Mon, 01 Jun 2026 21
- Embecta Completes Owen Mumford Acquisition to Expand Devices - The Globe and Mail Sat, 16 May 2026 07
- Embecta Corp. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts - Yahoo Finance Fri, 08 May 2026 07
- Diabetes tech firm embecta buys UK auto-injector maker for £100M - Stock Titan Fri, 15 May 2026 07
- Why Embecta's (NASDAQ:EMBC) Earnings Are Better Than They Seem - Yahoo Finance Wed, 13 May 2026 07
- We Think Embecta's (NASDAQ:EMBC) Solid Earnings Are Understated - Yahoo Finance hu, 12 Feb 2026 08
- Embecta (NYSE: EMBC) Schedule 13G/A — River Road reports 0 shares - Stock Titan Wed, 27 May 2026 15
- Investors can hear embecta management at BofA conference on May 13 - Stock Titan Fri, 08 May 2026 07
- S&P Global Ratings Cuts Credit Rating on Embecta (EMBC) After Revenue Decline - Yahoo Finance Wed, 13 May 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|---|
| Total Revenue |
|
1,080.40
-3.80%
|
1,123.10
+0.21%
|
1,120.80
-0.77%
|
1,129.50
|
| Operating Revenue |
|
1,080.40
-3.80%
|
1,123.10
+0.21%
|
1,120.80
-0.77%
|
1,129.50
|
| Cost Of Revenue |
|
403.60
+4.05%
|
387.90
+4.58%
|
370.90
+4.60%
|
354.60
|
| Reconciled Cost Of Revenue |
|
373.30
+4.27%
|
358.00
-3.48%
|
370.90
+4.60%
|
354.60
|
| Gross Profit |
|
676.80
-7.94%
|
735.20
-1.96%
|
749.90
-3.23%
|
774.90
|
| Operating Expense |
|
380.40
-15.50%
|
450.20
-14.39%
|
525.90
+29.40%
|
406.40
|
| Research And Development |
|
37.30
-52.66%
|
78.80
-7.51%
|
85.20
+27.35%
|
66.90
|
| Selling General And Administration |
|
332.00
-9.07%
|
365.10
+6.97%
|
341.30
+15.77%
|
294.80
|
| Selling And Marketing Expense |
|
—
|
—
|
—
|
—
|
| Other Operating Expenses |
|
0.70
|
—
|
99.40
+122.37%
|
44.70
|
| Total Expenses |
|
784.00
-6.46%
|
838.10
-6.55%
|
896.80
+17.84%
|
761.00
|
| Operating Income |
|
296.40
+4.00%
|
285.00
+27.23%
|
224.00
-39.21%
|
368.50
|
| Total Operating Income As Reported |
|
242.10
+45.14%
|
166.80
-24.70%
|
221.50
-28.46%
|
309.60
|
| EBITDA |
|
284.30
+47.54%
|
192.70
-21.44%
|
245.30
-26.67%
|
334.50
|
| Normalized EBITDA |
|
338.60
+8.91%
|
310.90
+25.46%
|
247.80
-37.01%
|
393.40
|
| Reconciled Depreciation |
|
40.70
+12.43%
|
36.20
+11.04%
|
32.60
+2.84%
|
31.70
|
| EBIT |
|
243.60
+55.65%
|
156.50
-26.42%
|
212.70
-29.76%
|
302.80
|
| Total Unusual Items |
|
-54.30
+54.06%
|
-118.20
-4628.00%
|
-2.50
+95.76%
|
-58.90
|
| Total Unusual Items Excluding Goodwill |
|
-54.30
+54.06%
|
-118.20
-4628.00%
|
-2.50
+95.76%
|
-58.90
|
| Special Income Charges |
|
-54.30
+54.06%
|
-118.20
-4628.00%
|
-2.50
+95.76%
|
-58.90
|
| Other Special Charges |
|
15.70
|
—
|
—
|
—
|
| Impairment Of Capital Assets |
|
0.00
|
0.00
-100.00%
|
2.50
-95.76%
|
58.90
|
| Restructuring And Mergern Acquisition |
|
38.60
-67.34%
|
118.20
+20.24%
|
98.30
|
—
|
| Net Income |
|
95.40
+21.84%
|
78.30
+11.22%
|
70.40
-68.52%
|
223.60
|
| Pretax Income |
|
136.30
+208.37%
|
44.20
-58.18%
|
105.70
-58.81%
|
256.60
|
| Net Non Operating Interest Income Expense |
|
-107.30
+4.45%
|
-112.30
-4.95%
|
-107.00
-131.60%
|
-46.20
|
| Interest Expense Non Operating |
|
107.30
-4.45%
|
112.30
+4.95%
|
107.00
+131.60%
|
46.20
|
| Net Interest Income |
|
-107.30
+4.45%
|
-112.30
-4.95%
|
-107.00
-131.60%
|
-46.20
|
| Interest Expense |
|
107.30
-4.45%
|
112.30
+4.95%
|
107.00
+131.60%
|
46.20
|
| Other Income Expense |
|
-52.80
+58.91%
|
-128.50
-1037.17%
|
-11.30
+82.80%
|
-65.70
|
| Other Non Operating Income Expenses |
|
1.50
+114.56%
|
-10.30
-17.05%
|
-8.80
-29.41%
|
-6.80
|
| Tax Provision |
|
40.90
+219.94%
|
-34.10
-196.60%
|
35.30
+6.97%
|
33.00
|
| Tax Rate For Calcs |
|
0.00
+42.86%
|
0.00
-37.13%
|
0.00
+158.91%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-16.29
+34.37%
|
-24.82
-2872.69%
|
-0.83
+89.01%
|
-7.60
|
| Net Income Including Noncontrolling Interests |
|
95.40
+21.84%
|
78.30
+11.22%
|
70.40
-68.52%
|
223.60
|
| Net Income From Continuing Operation Net Minority Interest |
|
95.40
+21.84%
|
78.30
+11.22%
|
70.40
-68.52%
|
223.60
|
| Net Income From Continuing And Discontinued Operation |
|
95.40
+21.84%
|
78.30
+11.22%
|
70.40
-68.52%
|
223.60
|
| Net Income Continuous Operations |
|
95.40
+21.84%
|
78.30
+11.22%
|
70.40
-68.52%
|
223.60
|
| Normalized Income |
|
133.41
-22.29%
|
171.68
+138.23%
|
72.06
-73.79%
|
274.90
|
| Net Income Common Stockholders |
|
95.40
+21.84%
|
78.30
+11.22%
|
70.40
-68.52%
|
223.60
|
| Diluted EPS |
|
1.62
+20.90%
|
1.34
+9.84%
|
1.22
-68.64%
|
3.89
|
| Basic EPS |
|
1.64
+20.59%
|
1.36
+10.57%
|
1.23
-68.62%
|
3.92
|
| Basic Average Shares |
|
58.31
+1.28%
|
57.57
+0.59%
|
57.24
+0.34%
|
57.04
|
| Diluted Average Shares |
|
58.91
+1.01%
|
58.33
+1.08%
|
57.70
+0.39%
|
57.48
|
| Diluted NI Availto Com Stockholders |
|
95.40
+21.84%
|
78.30
+11.22%
|
70.40
-68.52%
|
223.60
|
| Amortization |
|
10.40
+65.08%
|
6.30
|
0.00
|
—
|
| Amortization Of Intangibles Income Statement |
|
10.40
+65.08%
|
6.30
|
0.00
|
—
|
| Depreciation Amortization Depletion Income Statement |
|
10.40
+65.08%
|
6.30
|
0.00
|
—
|
| Depreciation And Amortization In Income Statement |
|
10.40
+65.08%
|
6.30
|
0.00
|
—
|
| Line Item | Trend | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|---|
| Total Assets |
|
1,090.90
-15.12%
|
1,285.30
+5.84%
|
1,214.40
+11.78%
|
1,086.40
|
| Current Assets |
|
631.40
-17.03%
|
761.00
+1.59%
|
749.10
+12.70%
|
664.70
|
| Cash Cash Equivalents And Short Term Investments |
|
225.50
-15.70%
|
267.50
-18.02%
|
326.30
-1.39%
|
330.90
|
| Cash And Cash Equivalents |
|
225.50
-15.70%
|
267.50
-18.02%
|
326.30
-1.39%
|
330.90
|
| Receivables |
|
148.90
-39.67%
|
246.80
+55.12%
|
159.10
+19.53%
|
133.10
|
| Accounts Receivable |
|
145.60
-24.56%
|
193.00
+1055.69%
|
16.70
-24.77%
|
22.20
|
| Gross Accounts Receivable |
|
147.40
-24.72%
|
195.80
+1006.21%
|
17.70
-24.68%
|
23.50
|
| Allowance For Doubtful Accounts Receivable |
|
-1.80
+35.71%
|
-2.80
-180.00%
|
-1.00
+23.08%
|
-1.30
|
| Inventory |
|
178.60
+4.14%
|
171.50
+12.75%
|
152.10
+23.86%
|
122.80
|
| Raw Materials |
|
50.00
+23.76%
|
40.40
+25.86%
|
32.10
+37.18%
|
23.40
|
| Work In Process |
|
11.70
+143.75%
|
4.80
-40.74%
|
8.10
+44.64%
|
5.60
|
| Finished Goods |
|
116.90
-7.44%
|
126.30
+12.87%
|
111.90
+19.30%
|
93.80
|
| Prepaid Assets |
|
—
|
—
|
—
|
77.90
|
| Restricted Cash |
|
3.10
-53.73%
|
6.70
+3250.00%
|
0.20
|
—
|
| Other Current Assets |
|
75.30
+9.93%
|
68.50
-38.51%
|
111.40
+43.00%
|
77.90
|
| Total Non Current Assets |
|
459.50
-12.36%
|
524.30
+12.68%
|
465.30
+10.34%
|
421.70
|
| Net PPE |
|
257.20
-11.43%
|
290.40
-3.26%
|
300.20
-0.46%
|
301.60
|
| Gross PPE |
|
791.30
+1.57%
|
779.10
+4.17%
|
747.90
+6.60%
|
701.60
|
| Accumulated Depreciation |
|
-534.10
-9.29%
|
-488.70
-9.16%
|
-447.70
-11.92%
|
-400.00
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Land And Improvements |
|
3.10
+0.00%
|
3.10
+34.78%
|
2.30
+64.29%
|
1.40
|
| Buildings And Improvements |
|
121.00
-0.58%
|
121.70
-2.25%
|
124.50
+0.65%
|
123.70
|
| Machinery Furniture Equipment |
|
595.40
-1.96%
|
607.30
+7.07%
|
567.20
+12.29%
|
505.10
|
| Construction In Progress |
|
58.60
+66.95%
|
35.10
-21.65%
|
44.80
-30.97%
|
64.90
|
| Leases |
|
13.20
+10.92%
|
11.90
+30.77%
|
9.10
+40.00%
|
6.50
|
| Goodwill And Other Intangible Assets |
|
22.40
-5.49%
|
23.70
-4.05%
|
24.70
+0.41%
|
24.60
|
| Goodwill |
|
15.40
-1.28%
|
15.60
+0.00%
|
15.60
-0.64%
|
15.70
|
| Other Intangible Assets |
|
7.00
-13.58%
|
8.10
-10.99%
|
9.10
+2.25%
|
8.90
|
| Non Current Deferred Assets |
|
—
|
—
|
—
|
95.50
|
| Non Current Deferred Taxes Assets |
|
—
|
—
|
—
|
95.50
|
| Other Non Current Assets |
|
179.90
-14.41%
|
210.20
+49.72%
|
140.40
+47.02%
|
95.50
|
| Total Liabilities Net Minority Interest |
|
1,742.10
-13.94%
|
2,024.20
-0.58%
|
2,036.10
+2.95%
|
1,977.80
|
| Current Liabilities |
|
261.50
-30.08%
|
374.00
+5.80%
|
353.50
+17.44%
|
301.00
|
| Payables And Accrued Expenses |
|
248.60
-31.15%
|
361.10
+6.08%
|
340.40
+18.24%
|
287.90
|
| Payables |
|
100.30
-37.39%
|
160.20
+0.00%
|
160.20
+18.58%
|
135.10
|
| Accounts Payable |
|
74.20
-18.46%
|
91.00
+70.09%
|
53.50
+29.23%
|
41.40
|
| Current Accrued Expenses |
|
148.30
-26.18%
|
200.90
+11.49%
|
180.20
+17.93%
|
152.80
|
| Total Tax Payable |
|
9.80
-63.30%
|
26.70
-20.54%
|
33.60
+23.53%
|
27.20
|
| Income Tax Payable |
|
9.80
-63.30%
|
26.70
-20.54%
|
33.60
+23.53%
|
27.20
|
| Current Debt And Capital Lease Obligation |
|
12.90
+0.00%
|
12.90
-1.53%
|
13.10
+0.00%
|
13.10
|
| Current Debt |
|
9.50
+0.00%
|
9.50
+0.00%
|
9.50
+0.00%
|
9.50
|
| Other Current Borrowings |
|
9.50
+0.00%
|
9.50
+0.00%
|
9.50
+0.00%
|
9.50
|
| Current Capital Lease Obligation |
|
3.40
+0.00%
|
3.40
-5.56%
|
3.60
+0.00%
|
3.60
|
| Total Non Current Liabilities Net Minority Interest |
|
1,480.60
-10.28%
|
1,650.20
-1.93%
|
1,682.60
+0.35%
|
1,676.80
|
| Long Term Debt And Capital Lease Obligation |
|
1,417.40
-11.16%
|
1,595.50
-1.84%
|
1,625.40
-0.33%
|
1,630.70
|
| Long Term Debt |
|
1,388.70
-11.28%
|
1,565.30
-1.79%
|
1,593.90
-0.26%
|
1,598.10
|
| Long Term Capital Lease Obligation |
|
28.70
-4.97%
|
30.20
-4.13%
|
31.50
-3.37%
|
32.60
|
| Non Current Deferred Liabilities |
|
—
|
—
|
—
|
46.10
|
| Non Current Deferred Taxes Liabilities |
|
—
|
—
|
—
|
46.10
|
| Other Non Current Liabilities |
|
63.20
+15.54%
|
54.70
-4.37%
|
57.20
+24.08%
|
46.10
|
| Stockholders Equity |
|
-651.20
+11.87%
|
-738.90
+10.08%
|
-821.70
+7.82%
|
-891.40
|
| Common Stock Equity |
|
-651.20
+11.87%
|
-738.90
+10.08%
|
-821.70
+7.82%
|
-891.40
|
| Capital Stock |
|
0.00
|
0.00
-100.00%
|
0.60
+0.00%
|
0.60
|
| Common Stock |
|
0.00
|
0.00
-100.00%
|
0.60
+0.00%
|
0.60
|
| Share Issued |
|
58.50
+1.37%
|
57.71
+0.65%
|
57.33
+0.49%
|
57.06
|
| Ordinary Shares Number |
|
58.50
+1.37%
|
57.71
+0.65%
|
57.33
+0.49%
|
57.06
|
| Additional Paid In Capital |
|
80.00
+52.38%
|
52.50
+88.17%
|
27.90
+179.00%
|
10.00
|
| Retained Earnings |
|
-445.60
+10.63%
|
-498.60
+7.85%
|
-541.10
+6.24%
|
-577.10
|
| Gains Losses Not Affecting Retained Earnings |
|
-285.60
+2.46%
|
-292.80
+5.27%
|
-309.10
+4.86%
|
-324.90
|
| Other Equity Adjustments |
|
-285.60
+2.46%
|
-292.80
+5.27%
|
-309.10
+4.86%
|
-324.90
|
| Total Equity Gross Minority Interest |
|
-651.20
+11.87%
|
-738.90
+10.08%
|
-821.70
+7.82%
|
-891.40
|
| Total Capitalization |
|
737.50
-10.76%
|
826.40
+7.02%
|
772.20
+9.27%
|
706.70
|
| Working Capital |
|
369.90
-4.42%
|
387.00
-2.17%
|
395.60
+8.77%
|
363.70
|
| Invested Capital |
|
747.00
-10.64%
|
835.90
+6.93%
|
781.70
+9.15%
|
716.20
|
| Total Debt |
|
1,430.30
-11.07%
|
1,608.40
-1.84%
|
1,638.50
-0.32%
|
1,643.80
|
| Net Debt |
|
1,172.70
-10.30%
|
1,307.30
+2.36%
|
1,277.10
+0.03%
|
1,276.70
|
| Capital Lease Obligations |
|
32.10
-4.46%
|
33.60
-4.27%
|
35.10
-3.04%
|
36.20
|
| Net Tangible Assets |
|
-673.60
+11.67%
|
-762.60
+9.90%
|
-846.40
+7.60%
|
-916.00
|
| Tangible Book Value |
|
-673.60
+11.67%
|
-762.60
+9.90%
|
-846.40
+7.60%
|
-916.00
|
| Duefrom Related Parties Current |
|
3.30
-93.87%
|
53.80
-62.22%
|
142.40
+28.40%
|
110.90
|
| Dueto Related Parties Current |
|
16.30
-61.65%
|
42.50
-41.86%
|
73.10
+9.92%
|
66.50
|
| Other Equity Interest |
|
—
|
—
|
—
|
—
|
| Line Item | Trend | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
191.70
+436.97%
|
35.70
-47.27%
|
67.70
-83.58%
|
412.20
|
| Cash Flow From Continuing Operating Activities |
|
191.70
+436.97%
|
35.70
-47.27%
|
67.70
-83.58%
|
412.20
|
| Net Income From Continuing Operations |
|
95.40
+21.84%
|
78.30
+11.22%
|
70.40
-68.52%
|
223.60
|
| Depreciation Amortization Depletion |
|
40.70
+12.43%
|
36.20
+11.04%
|
32.60
+2.84%
|
31.70
|
| Depreciation And Amortization |
|
40.70
+12.43%
|
36.20
+11.04%
|
32.60
+2.84%
|
31.70
|
| Other Non Cash Items |
|
19.50
+47.73%
|
13.20
+106.25%
|
6.40
+100.00%
|
3.20
|
| Pension And Employee Benefit Expense |
|
—
|
—
|
—
|
10.20
|
| Stock Based Compensation |
|
31.60
+20.15%
|
26.30
+22.33%
|
21.50
+14.97%
|
18.70
|
| Asset Impairment Charge |
|
10.60
|
0.00
-100.00%
|
2.50
-95.76%
|
58.90
|
| Deferred Tax |
|
17.60
+124.93%
|
-70.60
-593.71%
|
14.30
+153.96%
|
-26.50
|
| Deferred Income Tax |
|
17.60
+124.93%
|
-70.60
-593.71%
|
14.30
+153.96%
|
-26.50
|
| Operating Gains Losses |
|
—
|
—
|
—
|
10.20
|
| Change In Working Capital |
|
-23.70
+50.31%
|
-47.70
+40.38%
|
-80.00
-177.97%
|
102.60
|
| Change In Receivables |
|
44.20
+125.30%
|
-174.70
-2595.71%
|
7.00
-94.30%
|
122.70
|
| Changes In Account Receivables |
|
44.20
+125.30%
|
-174.70
-2595.71%
|
7.00
-94.30%
|
122.70
|
| Change In Inventory |
|
-6.10
+63.03%
|
-16.50
+42.71%
|
-28.80
-23.08%
|
-23.40
|
| Change In Prepaid Assets |
|
8.50
-78.48%
|
39.50
+378.17%
|
-14.20
+67.73%
|
-44.00
|
| Change In Payables And Accrued Expense |
|
-97.00
-232.51%
|
73.20
+1657.45%
|
-4.70
-105.39%
|
87.20
|
| Change In Payable |
|
-97.00
-232.51%
|
73.20
+1657.45%
|
-4.70
-105.39%
|
87.20
|
| Change In Account Payable |
|
-68.90
-214.83%
|
60.00
+659.49%
|
7.90
-89.73%
|
76.90
|
| Change In Other Working Capital |
|
26.70
-13.31%
|
30.80
+178.37%
|
-39.30
+1.50%
|
-39.90
|
| Change In Other Current Assets |
|
—
|
—
|
—
|
0.50
|
| Investing Cash Flow |
|
-9.30
+41.14%
|
-15.80
+40.38%
|
-26.50
-10.42%
|
-24.00
|
| Cash Flow From Continuing Investing Activities |
|
-9.30
+41.14%
|
-15.80
+40.38%
|
-26.50
-10.42%
|
-24.00
|
| Capital Expenditure |
|
-9.30
+41.14%
|
-15.80
+40.38%
|
-26.50
-10.42%
|
-24.00
|
| Capital Expenditure Reported |
|
-9.30
+41.14%
|
-15.80
+40.38%
|
-26.50
-12.29%
|
-23.60
|
| Net Intangibles Purchase And Sale |
|
—
|
0.00
|
0.00
+100.00%
|
-0.40
|
| Purchase Of Intangibles |
|
—
|
0.00
|
0.00
+100.00%
|
-0.40
|
| Financing Cash Flow |
|
-226.70
-208.86%
|
-73.40
-50.72%
|
-48.70
-1.46%
|
-48.00
|
| Cash Flow From Continuing Financing Activities |
|
-226.70
-208.86%
|
-73.40
-50.72%
|
-48.70
-1.46%
|
-48.00
|
| Net Issuance Payments Of Debt |
|
-186.00
-418.11%
|
-35.90
-235.51%
|
-10.70
-100.74%
|
1,437.80
|
| Issuance Of Debt |
|
—
|
0.00
|
0.00
-100.00%
|
1,450.00
|
| Repayment Of Debt |
|
-186.00
-418.11%
|
-35.90
-235.51%
|
-10.70
+12.30%
|
-12.20
|
| Long Term Debt Issuance |
|
—
|
0.00
|
0.00
-100.00%
|
1,450.00
|
| Long Term Debt Payments |
|
-186.00
-418.11%
|
-35.90
-235.51%
|
-10.70
-62.12%
|
-6.60
|
| Net Long Term Debt Issuance |
|
-186.00
-418.11%
|
-35.90
-235.51%
|
-10.70
-100.74%
|
1,443.40
|
| Short Term Debt Payments |
|
—
|
0.00
|
0.00
+100.00%
|
-5.60
|
| Net Short Term Debt Issuance |
|
—
|
0.00
|
0.00
+100.00%
|
-5.60
|
| Common Stock Dividend Paid |
|
-35.00
-1.45%
|
-34.50
-0.29%
|
-34.40
-300.00%
|
-8.60
|
| Cash Dividends Paid |
|
-35.00
-1.45%
|
-34.50
-0.29%
|
-34.40
-300.00%
|
-8.60
|
| Net Other Financing Charges |
|
-5.70
-90.00%
|
-3.00
+16.67%
|
-3.60
+99.76%
|
-1,477.20
|
| Changes In Cash |
|
-44.30
+17.20%
|
-53.50
-613.33%
|
-7.50
-102.20%
|
340.20
|
| Effect Of Exchange Rate Changes |
|
-1.30
-208.33%
|
1.20
-61.29%
|
3.10
+133.33%
|
-9.30
|
| Beginning Cash Position |
|
274.20
-16.02%
|
326.50
-1.33%
|
330.90
|
0.00
|
| End Cash Position |
|
228.60
-16.63%
|
274.20
-16.02%
|
326.50
-1.33%
|
330.90
|
| Free Cash Flow |
|
182.40
+816.58%
|
19.90
-51.70%
|
41.20
-89.39%
|
388.20
|
| Interest Paid Supplemental Data |
|
103.80
-11.81%
|
117.70
+6.04%
|
111.00
+185.35%
|
38.90
|
| Income Tax Paid Supplemental Data |
|
50.10
+72.16%
|
29.10
-4.28%
|
30.40
+94.87%
|
15.60
|
| Change In Income Tax Payable |
|
-28.10
-312.88%
|
13.20
+204.76%
|
-12.60
-222.33%
|
10.30
|
| Change In Tax Payable |
|
-28.10
-312.88%
|
13.20
+204.76%
|
-12.60
-222.33%
|
10.30
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-06-02 View
- 8-K2026-05-15 View
- 10-Q2026-05-05 View
- 8-K2026-05-05 View
- 8-K2026-03-20 View
- 42026-02-13 View
- 42026-02-13 View
- 42026-02-13 View
- 42026-02-13 View
- 42026-02-13 View
- 42026-02-13 View
- 8-K2026-02-13 View
- 10-Q2026-02-05 View
- 8-K2026-02-05 View
- 42025-12-01 View
- 42025-12-01 View
- 42025-12-01 View
- 42025-12-01 View
- 42025-12-01 View
- 42025-12-01 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|